SCHEMBL1709659

SCHEMBL1709659

CCN(CC)CCCS(=O)(=O)N(CCc1ccccc1)Cc1nc(-c2c[nH]c3ccccc23)n[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.41
HTR6 P50406 3/20 0.37
HTR1A P08908 2/20 0.37
KMT2A Q03164 4/20 0.36
TAAR1 Q96RJ0 1/20 0.36
KCNH2 Q12809 2/20 0.34
CHRM2 P08172 1/20 0.34
ADRA2A P08913 1/20 0.34
CHRM1 P11229 1/20 0.34
DRD1 P21728 1/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
ADRA1A P35348 1/20 0.34
OPRM1 P35372 1/20 0.34
DRD3 P35462 1/20 0.34
SLC6A3 Q01959 1/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1709538 0.93 GHSR (0.36) GHSRHTR6HTR1AKMT2AKCNH2
SCHEMBL1709537 0.79 GHSR (0.63) GHSRKMT2AALDH1A1MAPTPOLB
SCHEMBL1988787 0.78 GHSR (0.67) GHSRHTR6HTR1AKMT2AMEN1
SCHEMBL1709645 0.78 HTR6 (0.40) HTR6HTR1ASLC6A4ALDH1A1POLB
SCHEMBL1709539 0.71 HTR6 (0.39) HTR6HTR1ASLC6A4HTR1DMPO
SCHEMBL10121670 0.70 GHSR (0.61) GHSRHTR6HTR1AHTR1DHTR7
SCHEMBL1989289 0.69 GHSR (0.66) GHSRCDK1KDR
SCHEMBL1709736 0.69 KDM4E (0.38) GHSRKMT2AMEN1ALDH1A1KDM4E
SCHEMBL1994659 0.66 GHSR (0.58) GHSRHTR6HTR1AKMT2ATAAR1
SCHEMBL27743099 0.63 MEN1 (0.42) HTR1AKMT2AMEN1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF ELIXIR PHARMACEUTICALS, INC. 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088747-A1 SULFONAMIDE CONTAINING COMPOUNDS AND USES THEREOF GHSR, GHRHR, STS GHSR 1/4885HTR6 764/4885HTR1A 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.